H. Negaard, N. Iversen, I. Bowitz-lothe, P. Sandset, B. Steinsvik et al., Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors, Leukemia, vol.12, issue.1, pp.162-169, 2009.
DOI : 10.1038/leu.2008.255

G. Bocci, G. Francia, S. Man, J. Lawler, and R. Kerbel, Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy, Proceedings of the National Academy of Sciences, vol.98, issue.5, pp.12917-12922, 2003.
DOI : 10.1002/ijc.10247

L. Zitvogel, L. Apetoh, F. Ghiringhelli, F. André, A. Tesniere et al., The anticancer immune response: indispensable for therapeutic success?, Journal of Clinical Investigation, vol.118, issue.6, pp.1991-2001, 2008.
DOI : 10.1172/JCI35180
URL : http://www.jci.org/articles/view/35180/files/pdf

L. Sabatier, L. Camoin-jau, F. Anfosso, J. Sampol, and F. Dignat-george, Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence, Journal of Cellular and Molecular Medicine, vol.14, issue.3, pp.454-471, 2009.
DOI : 10.1016/S0002-9440(10)64887-0

L. Bonello, K. Harhouri, K. Baumstarck, L. Arnaud, N. Lesavre et al., Mobilization of CD34+KDR+ endothelial progenitor cells predicts target lesion revascularization, Journal of Thrombosis and Haemostasis, vol.2, issue.9, pp.1906-1913, 2012.
DOI : 10.1016/j.jcin.2009.03.013

Y. Shaked, E. Henke, and J. Roodhart, Rapid Chemotherapy-Induced Acute Endothelial Progenitor Cell Mobilization: Implications for Antiangiogenic Drugs as Chemosensitizing Agents, Cancer Cell, vol.14, issue.3, pp.263-73, 2008.
DOI : 10.1016/j.ccr.2008.08.001
URL : https://doi.org/10.1016/j.ccr.2008.08.001

P. Mancuso and F. Bertolini, Circulating endothelial cells as biomarkers in clinical oncology, Microvascular Research, vol.79, issue.3, pp.224-228, 2010.
DOI : 10.1016/j.mvr.2010.02.007

K. Miller, C. Sweeney, and G. Sledge, Redefining the Target: Chemotherapeutics as Antiangiogenics, Journal of Clinical Oncology, vol.19, issue.4, pp.1195-206, 2001.
DOI : 10.1200/JCO.2001.19.4.1195

M. Yan, G. Lesyk, A. Radziwon-balicka, and P. Jurasz, Pharmacological regulation of platelet factors that influence tumor angiogenesis Semin Oncol, pp.370-377, 2014.

E. Pasquier, M. Kavallaris, and N. André, Metronomic chemotherapy: new rationale for new directions, Nature Reviews Clinical Oncology, vol.1805, issue.8, pp.455-65, 2010.
DOI : 10.1016/0002-9394(77)90132-5

T. Brtnický, A. Fialová, J. La?tovi?ka, L. Rob, and R. ?pí?ek, Clinical relevance of regulatory T cells monitoring in the peripheral blood of ovarian cancer patients, Human Immunology, vol.76, issue.2-3, pp.76187-91, 2015.
DOI : 10.1016/j.humimm.2014.12.004

E. Hasnis, D. Alishekevitz, S. Gingis-veltski, R. Bril, E. Fremder et al., Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy, Neoplasia, vol.16, issue.6, pp.501-511, 2014.
DOI : 10.1016/j.neo.2014.05.011
URL : https://doi.org/10.1016/j.neo.2014.05.011

A. Woywodt, A. Blann, T. Kirsch, U. Erdbruegger, N. Banzet et al., Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol, Journal of Thrombosis and Haemostasis, vol.2, issue.3, pp.671-677, 2006.
DOI : 10.1002/ajh.10101

S. Robert, P. Poncelet, R. Lacroix, L. Arnaud, L. Giraudo et al., Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?, Journal of Thrombosis and Haemostasis, vol.16, issue.1, pp.190-197, 2009.
DOI : 10.1002/cyto.a.20354

D. Sutherland, L. Anderson, M. Keeney, R. Nayar, and I. Chin-yee, The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry, Journal of Hematotherapy, vol.5, issue.3, pp.213-239, 1996.
DOI : 10.1089/scd.1.1996.5.213

X. Valencia, C. Yarboro, G. Illei, and P. Lipsky, Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus, The Journal of Immunology, vol.178, issue.4, pp.2759-2588, 2007.
DOI : 10.4049/jimmunol.178.4.2579